IBA

IBAB.BR (ISIN: BE0003766806)

IBA (Ion Beam Applications) is in the business of providing equipment to businesses within the nuclear medicine and cancer therapy markets.         

Market: Euronext Brussels

http://www.iba-worldwide.com

Fair value: 50 €
Discount: 25%
Average yearly return: 43%
Yield: 0.7%
Outperformer

On November 16, 2016 IBA announced:

• Group revenue up 19.3%, full year 2016 revenue growth guidance of approximately 20%
• Continued strong growth in Proton Therapy, with Proton Therapy and Other Accelerators setting a new record backlog of EUR 362.6 million
• FY operating margin expected to be around 10% due to slower Dosimetry business